RFID meeting
This article was originally published in The Tan Sheet
Executive Summary
A public workshop Feb. 8-9 will allow FDA's Counterfeit Drug Task Force to collect stakeholder input on identifying "incentives for widespread adoption of radio frequency identification (RFID), as well as obstacles," according to a Federal Register announcement Jan. 11. Specifically, the agency seeks input on how to address the likelihood that widespread RFID technology will not be in operation by the current deadline for implementation under the Prescription Drug Marketing Act's pedigree requirements. Comments will "guide the agency's decision whether to continue the delayed effective date, let the regulatory provisions go into effect, or take other steps," the announcement states. In 2004, FDA cited implementation of electronic track and trace capability by 2007 as a priority. However, "it appears that the goals described previously may not be met," FDA states...